Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Palliative Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Allan, S. G
Right arrow Search for Related Content
PubMed
Right arrow Articles by Allan, S. G
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Review article : Emesis in the patient with advanced cancer

Simon G Allan

Imperial Cancer Research Fund, Medical Oncology Unit, Western General Hospital, Edinburgh

The control of symptoms related to far advanced cancer has improved dramatically in recent years, making the passage of death more tolerable for such patients. The major impact of analgesic control now allows research efforts to focus on other distressing symptoms such as nausea and vomiting. The emetic process is a complex physiological and psychological one of multifactorial aetiology. Rapid improvement in our understanding of these processes is allowing the more rational use of known antiemetics and the development of new antiemetic agents. A rapid expansion of the literature of cytotoxic-induced emesis has pointed to new antiemetic agents and new schedules of administration.

This review emphasises the need to identify the cause of emesis before attempting indirectly to block the emetic process with antiemetic drugs. It also outlines the many areas where research could be applied to unravel some of the questions about which antiemetic to use, in what dose, and perhaps to identify the main site of emetic stimulus. More effective research is required, but the outlook for improved control of nausea and vomiting in the terminally ill patient is good.

Key Words: antiemetics • antineoplastic agents • nausea • neoplasms • palliative treatment • vomiting

Palliative Medicine, Vol. 2, No. 2, 89-100 (1988)
DOI: 10.1177/026921638800200202


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
AM J HOSP PALLIAT CAREHome page
P. Rousseau
Antiemetic therapy in adults with terminal disease: A brief review
American Journal of Hospice and Palliative Medicine, January 1, 1995; 12(1): 13 - 18.
[Abstract] [PDF]


Home page
Palliat MedHome page
C. Regnard and M. Comiskey
Nausea and vomiting in advanced cancer-a flow diagram
Palliative Medicine, April 1, 1992; 6(2): 146 - 151.
[Abstract] [PDF]